Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Ondo, Williama; * | Coss, Pablob | Christie, Melissab | Pascual, Belena
Affiliations: [a] Methodist Neurological Institute, Houston, TX, USA | [b] University of Texas Health Science Center, Houston, TX, USA
Correspondence: [*] Correspondence to: William Ondo, MD, Methodist Neurological Institute, 6560 Fannin, Ste 1002, Houston, TX, USA. Tel.: +1 713 412 9631; E-mail: [email protected].
Abstract: Background:A new extended release levodopa capsule (C/L ERC), Rytary®, has demonstrated improved “on” time in fluctuating Parkinson’s disease patients, compared to optimally dosed immediate release levodopa. The milligram dosing, however, differs markedly and no empiric ratio or formula for dose conversion currently exists. Objective:To determine the most effective conversion strategy from C/L to C/L ERC. Methods:We reviewed fluctuating PD patients with problematic “off” time who were converted to C/L ERC using a semi-structured dose titration schedule, and collected data regarding basic efficacy, tolerability, and dosing, in order to determine an empirically based dose conversion formula. We collected demographics, PD historic data, and other medication use. Results:Eighty fluctuating PD patients were given C/L ERC samples, 68 took at least one dose [46 male (67.6%), age 66.6±10.3 y], and 62 had adequate data for dose convergence calculations. At a mean follow-up of 119±101 days, [Range: 24–355 days], 43/68 (63.3%) remained on C/L ERC. CGI-I of “much improved” or “very much improved” was reported by 27/62 (43.5%) and dyskinesia scores from the Movement Disorder Society Unified Parkinson’s Disease Rating Scale item 4.1, (0–4 range)) tended to improve from 0.9±1.1 to 0.5±0.6, P = 0.08. The mean individual daily ratio was 2.0±0.6 : 1, [range 1.0–3.5]. A lower number of baseline daily L-dopa doses predicted a higher conversion ratio, but pre-conversion dyskinesia did not. Conclusions:This retrospective study found that C/L ERC was generally well tolerated and preferred by many patients. The mean total daily conversion ratio is 2 : 1.
Keywords: Parkinson’s disease, levodopa, rytary
DOI: 10.3233/JPD-181427
Journal: Journal of Parkinson's Disease, vol. 9, no. 1, pp. 153-156, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]